Global Injectable Drug Delivery Formulation Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Injectable Drug Delivery Formulation

• 1.1 Definition of Injectable Drug Delivery Formulation
• 1.2 Injectable Drug Delivery Formulation Segment by Type
  • 1.2.1 Global Injectable Drug Delivery Formulation Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Conventional Drug Delivery Formulations
  • 1.2.3 Novel Drug Delivery Formulations
  • 1.2.4 Long-acting Formulations
• 1.3 Injectable Drug Delivery Formulation Segment by Applications
  • 1.3.1 Global Injectable Drug Delivery Formulation Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Autoimmune Diseases
  • 1.3.3 Hormonal Disorders
  • 1.3.4 Oncology
  • 1.3.5 Orphan Diseases
  • 1.3.6 Others
• 1.4 Global Injectable Drug Delivery Formulation Overall Market
  • 1.4.1 Global Injectable Drug Delivery Formulation Revenue (2014-2025)
  • 1.4.2 Global Injectable Drug Delivery Formulation Production (2014-2025)
  • 1.4.3 North America Injectable Drug Delivery Formulation Status and Prospect (2014-2025)
  • 1.4.4 Europe Injectable Drug Delivery Formulation Status and Prospect (2014-2025)
  • 1.4.5 China Injectable Drug Delivery Formulation Status and Prospect (2014-2025)
  • 1.4.6 Japan Injectable Drug Delivery Formulation Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Injectable Drug Delivery Formulation Status and Prospect (2014-2025)
  • 1.4.8 India Injectable Drug Delivery Formulation Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Injectable Drug Delivery Formulation
• 2.3 Manufacturing Process Analysis of Injectable Drug Delivery Formulation
• 2.4 Industry Chain Structure of Injectable Drug Delivery Formulation

3 Development and Manufacturing Plants Analysis of Injectable Drug Delivery Formulation

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Injectable Drug Delivery Formulation Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Injectable Drug Delivery Formulation
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Injectable Drug Delivery Formulation Production and Capacity Analysis
• 4.2 Injectable Drug Delivery Formulation Revenue Analysis
• 4.3 Injectable Drug Delivery Formulation Price Analysis
• 4.4 Market Concentration Degree

5 Injectable Drug Delivery Formulation Regional Market Analysis

• 5.1 Injectable Drug Delivery Formulation Production by Regions
  • 5.1.1 Global Injectable Drug Delivery Formulation Production by Regions
  • 5.1.2 Global Injectable Drug Delivery Formulation Revenue by Regions
• 5.2 Injectable Drug Delivery Formulation Consumption by Regions
• 5.3 North America Injectable Drug Delivery Formulation Market Analysis
  • 5.3.1 North America Injectable Drug Delivery Formulation Production
  • 5.3.2 North America Injectable Drug Delivery Formulation Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Injectable Drug Delivery Formulation Import and Export
• 5.4 Europe Injectable Drug Delivery Formulation Market Analysis
  • 5.4.1 Europe Injectable Drug Delivery Formulation Production
  • 5.4.2 Europe Injectable Drug Delivery Formulation Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Injectable Drug Delivery Formulation Import and Export
• 5.5 China Injectable Drug Delivery Formulation Market Analysis
  • 5.5.1 China Injectable Drug Delivery Formulation Production
  • 5.5.2 China Injectable Drug Delivery Formulation Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Injectable Drug Delivery Formulation Import and Export
• 5.6 Japan Injectable Drug Delivery Formulation Market Analysis
  • 5.6.1 Japan Injectable Drug Delivery Formulation Production
  • 5.6.2 Japan Injectable Drug Delivery Formulation Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Injectable Drug Delivery Formulation Import and Export
• 5.7 Southeast Asia Injectable Drug Delivery Formulation Market Analysis
  • 5.7.1 Southeast Asia Injectable Drug Delivery Formulation Production
  • 5.7.2 Southeast Asia Injectable Drug Delivery Formulation Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Injectable Drug Delivery Formulation Import and Export
• 5.8 India Injectable Drug Delivery Formulation Market Analysis
  • 5.8.1 India Injectable Drug Delivery Formulation Production
  • 5.8.2 India Injectable Drug Delivery Formulation Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Injectable Drug Delivery Formulation Import and Export

6 Injectable Drug Delivery Formulation Segment Market Analysis (by Type)

• 6.1 Global Injectable Drug Delivery Formulation Production by Type
• 6.2 Global Injectable Drug Delivery Formulation Revenue by Type
• 6.3 Injectable Drug Delivery Formulation Price by Type

7 Injectable Drug Delivery Formulation Segment Market Analysis (by Application)

• 7.1 Global Injectable Drug Delivery Formulation Consumption by Application
• 7.2 Global Injectable Drug Delivery Formulation Consumption Market Share by Application (2014-2019)

8 Injectable Drug Delivery Formulation Major Manufacturers Analysis

• 8.1 Becton, Dickinson and Company (U.S.)
  • 8.1.1 Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.1.2 Becton, Dickinson and Company (U.S.) Product Introduction, Application and Specification
  • 8.1.3 Becton, Dickinson and Company (U.S.) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Baxter International Inc. (U.S.)
  • 8.2.1 Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.2.2 Baxter International Inc. (U.S.) Product Introduction, Application and Specification
  • 8.2.3 Baxter International Inc. (U.S.) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Gerresheimer AG (Germany)
  • 8.3.1 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.3.2 Gerresheimer AG (Germany) Product Introduction, Application and Specification
  • 8.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Pfizer, Inc. (U.S.)
  • 8.4.1 Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.4.2 Pfizer, Inc. (U.S.) Product Introduction, Application and Specification
  • 8.4.3 Pfizer, Inc. (U.S.) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Schott AG (Germany)
  • 8.5.1 Schott AG (Germany) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.5.2 Schott AG (Germany) Product Introduction, Application and Specification
  • 8.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sandoz (Germany)
  • 8.6.1 Sandoz (Germany) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.6.2 Sandoz (Germany) Product Introduction, Application and Specification
  • 8.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Teva Pharmaceutical Industries Ltd. (Israel)
  • 8.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Product Introduction, Application and Specification
  • 8.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Eli Lilly and Company (U.S.)
  • 8.8.1 Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Production Sites and Area Served
  • 8.8.2 Eli Lilly and Company (U.S.) Product Introduction, Application and Specification
  • 8.8.3 Eli Lilly and Company (U.S.) Injectable Drug Delivery Formulation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Injectable Drug Delivery Formulation Market

• 9.1 Global Injectable Drug Delivery Formulation Market Trend Analysis
  • 9.1.1 Global Injectable Drug Delivery Formulation Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Injectable Drug Delivery Formulation Regional Market Trend
  • 9.2.1 North America Injectable Drug Delivery Formulation Forecast 2019-2025
  • 9.2.2 Europe Injectable Drug Delivery Formulation Forecast 2019-2025
  • 9.2.3 China Injectable Drug Delivery Formulation Forecast 2019-2025
  • 9.2.4 Japan Injectable Drug Delivery Formulation Forecast 2019-2025
  • 9.2.5 Southeast Asia Injectable Drug Delivery Formulation Forecast 2019-2025
  • 9.2.6 India Injectable Drug Delivery Formulation Forecast 2019-2025
• 9.3 Injectable Drug Delivery Formulation Market Trend (Product Type)
• 9.4 Injectable Drug Delivery Formulation Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Injectable Drug Delivery Formulation Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List